Cargando…

Renin–angiotensin system inhibitor use and the risk of mortality in hospitalized patients with COVID-19: a meta-analysis of randomized controlled trials

Detalles Bibliográficos
Autores principales:	Kow, Chia Siang, Ming, Long Chiau, Hasan, Syed Shahzad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Singapore 2021
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8134827/ https://www.ncbi.nlm.nih.gov/pubmed/34017093 http://dx.doi.org/10.1038/s41440-021-00670-w

Ejemplares similares

Cardiovascular Disease and Use of Renin-Angiotensin System Inhibitors in COVID-19
por: Kow, Chia Siang, et al.
Publicado: (2020)

Mortality and Disease Severity Among COVID-19 Patients Receiving Renin-Angiotensin System Inhibitors: A Systematic Review and Meta-analysis
por: Hasan, Syed Shahzad, et al.
Publicado: (2020)

The effect of colchicine on mortality outcome and duration of hospital stay in patients with COVID‐19: A meta‐analysis of randomized trials
por: Kow, Chia Siang, et al.
Publicado: (2021)

The effect of tocilizumab on mortality in hospitalized patients with COVID-19: a meta-analysis of randomized controlled trials
por: Kow, Chia Siang, et al.
Publicado: (2021)

How to make the best of NLRP3 inhibitors in patients with COVID-19?
por: Kow, Chia Siang, et al.
Publicado: (2023)

Use of rituximab and the risk of adverse clinical outcomes in COVID-19 patients with systemic rheumatic disease
por: Kow, Chia Siang, et al.
Publicado: (2020)

Role of frailty in COVID-19 patients
por: Kow, Chia Siang, et al.
Publicado: (2020)

Glucocorticoid versus immunoglobulin in the treatment of COVID-19-associated fulminant myocarditis
por: Kow, Chia Siang, et al.
Publicado: (2020)

Colchicine as an adjunct to heparin for prophylaxis of venous thromboembolism in patients with COVID-19
por: Kow, Chia Siang, et al.
Publicado: (2021)

Corticosteroid Plus Tocilizumab in COVID-19: When Two Is Better Than One
por: Kow, Chia Siang, et al.
Publicado: (2021)

Hypertension and severe COVID-19
por: Kow, Chia Siang, et al.
Publicado: (2023)

Coenzyme Q10 therapy in patients with post COVID-19 condition
por: Kow, Chia Siang, et al.
Publicado: (2023)

Favipiravir and hyperuricemia in patients with COVID-19—suggestions for future studies
por: Kow, Chia Siang, et al.
Publicado: (2023)

The effect of vitamin C on the risk of mortality in patients with COVID-19: a systematic review and meta-analysis of randomized controlled trials
por: Kow, Chia Siang, et al.
Publicado: (2023)

Use of antiplatelet drugs and the risk of mortality in patients with COVID-19: a meta‐analysis
por: Kow, Chia Siang, et al.
Publicado: (2021)

The risk of mortality in patients with COVID-19 with pre-diagnosis use of NSAIDs: a meta-analysis
por: Kow, Chia Siang, et al.
Publicado: (2021)

The effect of higher-intensity dosing of anticoagulation on the clinical outcomes in hospitalized patients with COVID-19: A meta-analysis of randomized controlled trials
por: Kow, Chia Siang, et al.
Publicado: (2022)

A meta-analysis on the preadmission use of DPP-4 inhibitors and risk of a fatal or severe course of illness in patients with COVID-19
por: Kow, Chia Siang, et al.
Publicado: (2021)

Association of frailty and mortality in patients with COVID-19: a meta-analysis
por: Kow, Chia S., et al.
Publicado: (2021)

Use of DPP-4 inhibitors in patients with COVID-19
por: Kow, Chia Siang, et al.
Publicado: (2020)

Meta-analysis of Effect of Statins in Patients with COVID-19
por: Kow, Chia Siang, et al.
Publicado: (2020)

Intermediate- to high-dose dexamethasone versus low-dose dexamethasone in patients with COVID-19 requiring respiratory support: a systematic review and meta-analysis of randomized trials
por: Kow, Chia Siang, et al.
Publicado: (2023)

The impact of preadmission/prediagnosis use of GLP‐1 receptor agonists on COVID‐19 mortality in patients with diabetes: A systematic review and meta‐analysis
por: Kow, Chia Siang, et al.
Publicado: (2023)

The Association Between the Use of Statins and Clinical Outcomes in Patients with COVID-19: A Systematic Review and Meta-analysis
por: Kow, Chia Siang, et al.
Publicado: (2021)

The risk of mortality and severe illness in patients infected with the omicron variant relative to delta variant of SARS-CoV-2: a systematic review and meta-analysis
por: Kow, Chia Siang, et al.
Publicado: (2023)

Real-world effectiveness of BNT162b2 mRNA vaccine: a meta-analysis of large observational studies
por: Kow, Chia Siang, et al.
Publicado: (2021)

The association between the use of ivermectin and mortality in patients with COVID-19: a meta-analysis
por: Kow, Chia Siang, et al.
Publicado: (2021)

Downregulation of ACE2 induces overstimulation of the renin–angiotensin system in COVID-19: should we block the renin–angiotensin system?
por: Silhol, François, et al.
Publicado: (2020)

RAAS inhibitors in COVID-19: not all are created equal!
por: Kow, Chia Siang, et al.
Publicado: (2023)

Covid-19, hypokalaemia and the renin-angiotensin-aldosterone system
por: Mandal, Amit.K.J., et al.
Publicado: (2021)

Combination Therapy with CCBs and RAS Inhibitors to Counteract Endothelial Dysfunction in COVID-19
por: Kow, Chia Siang, et al.
Publicado: (2022)

Mortality risk in patients infected with SARS-CoV-2 of the lineage B.1.1.7 in the UK
por: Kow, Chia Siang, et al.
Publicado: (2021)

High Renin Concentrations in Severe COVID-19 Are Indicative for a Hypo–Renin–Angiotensin-System State
por: Akin, Sakir, et al.
Publicado: (2022)

Clinical outcomes of hypertensive patients with COVID-19 receiving calcium channel blockers: a systematic review and meta-analysis
por: Kow, Chia Siang, et al.
Publicado: (2021)

Macrolides for patients with COVID-19 and concurrent pertussis infection
por: Kow, Chia Siang, et al.
Publicado: (2021)

Concurrent Antibiotic Therapy in Disseminated Strongyloidiasis
por: Kow, Chia Siang, et al.
Publicado: (2020)

Pharmacotherapeutic considerations for systemic rheumatic diseases amid the COVID-19 pandemic: more questions than answers
por: Kow, Chia Siang, et al.
Publicado: (2020)

Use of Azithromycin in COVID-19: A Cautionary Tale
por: Kow, Chia Siang, et al.
Publicado: (2020)

Revascularization strategy in patients with acute ST-elevation myocardial infarction amid COVID-19 pandemic
por: Kow, Chia Siang, et al.
Publicado: (2021)

Use of low-molecular-weight heparin in COVID-19 patients
por: Kow, Chia Siang, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_teborhdcdkpobge8gjfd440mq1